Aldagen
Durham, US · 1 known investors
Founders & leadership
LA
LYLE A. HOHNKEExecutive
JH
JAMES HINSONExecutive
EF
EDWARD FIELDExecutive
Board
MM
MARTIN MURPHYBoard director
BJ
B. JEFFERSON CLARKBoard director
RK
RICHARD KENTBoard director
WE
WILLIAM EVANSBoard director
WB
WILLIAM BROOKEBoard director
DD
DENNIS DOUGHERTYBoard director
JK
JOEL KIMBROUGHBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$585K disclosed across 1 round · 2011
▶$585KraisedJan 2012 · 13 investors · BiotechnologyRule 506(b)
▶$585KraisedJan 2012 · 13 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- MARTIN MURPHYDirector
- B. JEFFERSON CLARKDirector
- RICHARD KENTDirector
- LYLE A. HOHNKEExecutive Officer, Director
- WILLIAM EVANSDirector
- JAMES HINSONExecutive Officer
- WILLIAM BROOKEDirector
- DENNIS DOUGHERTYDirector
- JOEL KIMBROUGHDirector
- EDWARD FIELDExecutive Officer
- Offering amount
- $645K
- Amount sold
- $585K
- First sale
- Sep 2011
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- Who are Aldagen's investors?
- Aldagen's investors include New Markets Venture Partners.
- How much funding has Aldagen raised?
- Aldagen has disclosed $585K raised across 1 round.
- Where is Aldagen headquartered?
- Aldagen is headquartered in Durham, US.